For Orient Paper Inc’s (AMEX:ONP) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important.
Oragenics, Inc., a biotechnology company focused on intranasal therapies for brain-related disorders, has announced a management update webinar scheduled for May 20, 2025, at 4:00 PM ET to discuss its ...
SARASOTA, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, ...
On Thursday, Oragenics Inc. (NYSE:OGEN) announced that its lead candidate for treating concussion completed a study that indicates ONP-002 does not cause cardiotoxicity. ONP-002 is a new chemical ...
Oragenics, Inc., a biotech company focused on intranasal therapeutics for brain-related conditions, announced that its Head of Business Development, Greg Gironda, will present at the 2025 BIO ...
First off, I am going to briefly examine the outlook for supply and demand for ONP (old newspapers) in North America and then move on to how the decline in readership has affected the residential ...
HERMOSA BEACH, Calif.--(BUSINESS WIRE)--Ortega National Parks (ONP) announces that Nolan Capital, Inc., the family office of Peter Nolan, has become the company’s majority owner. This sale will enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results